THE PHILOSOPHY OF SURGICAL DECISION-MAKING
In the realm of operative orthopaedics, the decision to intervene surgically is often more complex than the execution of the procedure itself. As orthopaedic pioneers Boyd, Lipinski, and Wiley astutely observed, good surgical judgment comes from experience, and experience invariably comes from bad surgical judgment. The modern orthopaedic surgeon must navigate a delicate balance between the mechanical necessity of fracture stabilization and the biological capacity of the patient to tolerate the intervention and heal the subsequent construct.
Just as there are rarely absolute indications for the surgical management of a fracture, there are virtually no absolute contraindications. However, the fundamental tenet of surgical intervention remains: primum non nocere (first, do no harm). If the possibility of a successful surgical outcome is overshadowed by the high probability of catastrophic complications, hardware failure, or profound morbidity, nonoperative treatment or alternative damage-control strategies must be employed.
Clinical Pearl: The "personality of the fracture" must always be weighed against the "personality of the patient." A biomechanically perfect osteosynthesis is a clinical failure if the soft tissue envelope undergoes necrosis or the patient succumbs to systemic stress.
CONTRAINDICATIONS TO SURGICAL REDUCTION AND STABILIZATION
While absolute contraindications are rare, numerous relative contraindications dictate a shift from Early Total Care (ETC) to Damage Control Orthopaedics (DCO) or definitive nonoperative management.
Systemic Contraindications
- Hemodynamic Instability: Patients in extremis (e.g., profound hemorrhagic shock, severe coagulopathy, acidosis, and hypothermia—the "lethal triad") cannot tolerate the physiological second hit of definitive fracture reduction and internal fixation.
- Severe Pulmonary Compromise: In polytrauma patients with severe bilateral pulmonary contusions or Acute Respiratory Distress Syndrome (ARDS), intramedullary reaming and prolonged surgical times can exacerbate systemic inflammatory response syndrome (SIRS).
- Non-Ambulatory Baseline Status: In patients with severe baseline dementia, paraplegia, or terminal illness, the risks of major reconstructive surgery (e.g., complex acetabular fixation) often outweigh the functional benefits. Palliative or minimally invasive stabilization is preferred.
Local Contraindications
- Compromised Soft Tissue Envelope: Severe fracture blisters, massive degloving injuries (Morel-Lavallée lesions), or active local infection absolutely contraindicate immediate internal fixation. Incising through compromised tissue guarantees wound dehiscence and deep infection.
- Inadequate Bone Stock: Severe, uncorrectable osteopenia or osteoporosis where hardware purchase is impossible may contraindicate standard plating, necessitating alternative strategies such as spanning external fixation, intramedullary devices, or augmentation with polymethylmethacrylate (PMMA).
FACTORS THAT NEGATIVELY AFFECT BONE HEALING
When surgical reduction is performed, the ultimate success of the procedure relies on the biological cascade of bone healing. Numerous systemic, pharmacological, and biomechanical factors have been proven to exert a profound negative effect on osteogenesis.
Tobacco and Nicotine Use
Tobacco smoking is arguably the most notable and modifiable risk factor negatively affecting bone healing. Clinical and animal studies have unequivocally demonstrated that smoking, previous smoking, and the use of smokeless tobacco significantly delay fracture healing and increase the risk of nonunion.
- Pathophysiology: Nicotine is a potent vasoconstrictor that diminishes peripheral blood flow, leading to tissue hypoxia. Furthermore, carbon monoxide in cigarette smoke binds to hemoglobin with an affinity 200 times greater than oxygen, shifting the oxyhemoglobin dissociation curve to the left and further starving the fracture hematoma of oxygen. Hydrogen cyanide inhibits cellular respiration at the mitochondrial level.
- Clinical Impact: Smoking may double the time required for a fracture to heal. It significantly increases the risk of nonunion, particularly in watershed areas such as the tibial diaphysis and the scaphoid. Tobacco use also profoundly delays simple wound healing, increasing the risk of surgical site infections (SSIs) and flap necrosis.
Surgical Warning: Elective arthrodesis or complex osteotomies should be strictly delayed until the patient has achieved documented smoking cessation for a minimum of 4 to 6 weeks preoperatively, confirmed via serum or urine cotinine levels.
Pharmacological Agents
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
NSAIDs, including both non-selective (cyclooxygenase-1) and selective (cyclooxygenase-2) inhibitors, have been shown to delay or completely arrest the bone healing cascade.
- Mechanism of Action: Fracture healing, particularly endochondral ossification, relies heavily on the initial inflammatory phase. Prostaglandins (specifically PGE2), synthesized via the COX-2 pathway, are critical for the differentiation of mesenchymal stem cells into osteoblasts and for the regulation of angiogenesis.
- Clinical Impact: By inhibiting prostaglandin synthesis, NSAIDs blunt the inflammatory phase. Ibuprofen, in particular, has been implicated in stopping the bone healing cascade entirely in certain animal models. The inhibitory effects vary depending on the specific drug, dosage, and duration of use.
- Recommendation: Avoid NSAIDs during the first 4 to 6 weeks of fracture healing or following spinal fusion/osteotomy procedures. Rely on acetaminophen, localized blocks, and judicious use of opioids for postoperative analgesia.
Fluoroquinolone Antibiotics
The fluoroquinolone family of antibiotics (e.g., ciprofloxacin, levofloxacin) has been implicated in slowing bone healing and impairing tendon integrity.
* Mechanism: Fluoroquinolones are known to be toxic to chondrocytes and can inhibit DNA gyrase, negatively impacting collagen synthesis and matrix production during the soft callus phase of healing.
* Clinical Context: Despite their negative impact on osteogenesis, these drugs remain highly effective in the outpatient treatment of deep bone infections (osteomyelitis) due to their excellent oral bioavailability and bone penetration. The surgeon must weigh the risk of delayed healing against the necessity of eradicating a deep infection.
Biomechanical Factors and Mechanobiology
Bone healing is a mechanically driven process governed by Perren’s Strain Theory and Wolff’s Law.
- Lack of Mechanical Stimulation: A complete lack of weight-bearing or muscular stimulation at the fracture site deprives the healing callus of the micromotion necessary to stimulate secondary (endochondral) bone healing.
- Over-Rigid Fixation: Conversely, absolute stability (e.g., rigid compression plating) without perfect anatomical reduction can lead to nonunion, as the construct prevents the micromotion needed for callus formation but fails to provide the intimate bone contact required for primary (Haversian) healing.
Systemic Comorbidities
Systemic diseases profoundly alter the microenvironment of the fracture site.
* Diabetes Mellitus: Hyperglycemia leads to the accumulation of Advanced Glycation End-products (AGEs), which stiffen collagen and impair osteoblast function. Microvascular disease decreases blood flow to the fracture site, while peripheral neuropathy increases the risk of Charcot arthropathy and hardware failure due to unrecognized repetitive microtrauma.
* Malnutrition: Deficiencies in Vitamin D, calcium, and protein (albumin < 3.5 g/dL) severely impair callus formation and mineralization.
ALTERNATIVE SURGICAL APPROACHES: DAMAGE CONTROL ORTHOPAEDICS
When definitive surgical reduction and internal fixation are contraindicated due to the factors listed above, the surgeon must pivot to alternative stabilization methods. The most common approach is the application of a spanning external fixator.
Step-by-Step: Spanning Knee External Fixation (Damage Control for Proximal Tibia/Distal Femur)
When severe soft tissue swelling (e.g., Tscherne Grade III closed injury) contraindicates immediate plating of a tibial plateau fracture, a spanning external fixator provides skeletal stability while allowing soft tissue resuscitation.
1. Positioning and Preparation
- Place the patient supine on a radiolucent Jackson or flat Jackson table.
- Ensure fluoroscopic access (C-arm) from the hip to the ankle.
- Prep and drape the entire lower extremity from the iliac crest to the toes.
2. Femoral Pin Placement
- Identify the safe zones. The anterolateral or direct anterior approach to the distal femur is utilized to avoid the neurovascular bundle medially.
- Make a 1 cm stab incision over the anterolateral distal femur, spreading bluntly down to the bone with a hemostat to protect the vastus lateralis muscle fibers.
- Use a tissue protector. Drill bicortically using a 3.2 mm or 4.5 mm drill bit (depending on the pin system).
- Insert two 5.0 mm half-pins bicortically, spaced approximately 5-8 cm apart. Ensure the pins are parallel to the joint line in the coronal plane.
3. Tibial Pin Placement
- Identify the tibial diaphysis safe zone (anterior or anteromedial face).
- Make stab incisions and spread bluntly to the periosteum to avoid the saphenous vein and nerve medially, or the anterior tibial artery laterally.
- Drill and insert two 5.0 mm half-pins bicortically into the tibial shaft, ensuring adequate distance from the planned future surgical incision for definitive plating.
4. Reduction and Frame Assembly
- Apply manual longitudinal traction to restore length, alignment, and rotation (gross reduction).
- Connect the femoral and tibial pins using carbon fiber rods and bar-to-pin clamps.
- Construct a delta frame or a biplanar construct for added rigidity.
- Tighten all clamps sequentially while maintaining traction.
- Confirm reduction and pin placement via orthogonal fluoroscopic views.
Surgical Pitfall: Placing external fixator pins within the zone of future definitive surgical incisions increases the risk of deep infection during subsequent internal fixation. Always plan pin placement outside the anticipated surgical field.
POSTOPERATIVE PROTOCOLS FOR HIGH-RISK PATIENTS
When surgery is performed on patients with multiple risk factors for delayed healing or nonunion, the postoperative protocol must be meticulously tailored to mitigate these risks.
1. Modified Weight-Bearing Progression
In patients with compromised healing potential (e.g., severe diabetics, chronic smokers), the standard timeline for weight-bearing must be extended.
* Phase 1 (0-6 weeks): Strict non-weight-bearing (NWB) or touch-down weight-bearing (TDWB) to protect the hardware from fatigue failure while the delayed soft callus forms.
* Phase 2 (6-12 weeks): Progressive partial weight-bearing (PWB), guided strictly by radiographic evidence of bridging callus on at least three out of four cortices.
2. Pharmacological and Biological Adjuncts
- Bone Stimulators: The use of Low-Intensity Pulsed Ultrasound (LIPUS) or Pulsed Electromagnetic Field (PEMF) therapy should be considered early in the postoperative course for patients with a high risk of nonunion.
- Nutritional Optimization: Initiate aggressive supplementation of Vitamin D3 (target serum 25-OH Vitamin D > 40 ng/mL), calcium citrate, and high-protein diets.
- Glycemic Control: Maintain strict perioperative and postoperative glycemic control, targeting an HbA1c of < 7.0% and perioperative blood glucose levels between 140-180 mg/dL to optimize macrophage function and reduce SSI risk.
3. Deep Vein Thrombosis (DVT) Prophylaxis
High-risk patients often require prolonged immobilization. Chemical prophylaxis (e.g., Low Molecular Weight Heparin) is mandatory unless contraindicated. Notably, while some animal studies suggest high-dose heparins may affect bone healing, the clinical risk of fatal pulmonary embolism far outweighs the theoretical risk of delayed union.
CONCLUSION
The decision to proceed with surgical reduction and stabilization is a complex calculus of biomechanics, biology, and patient-specific factors. Recognizing the contraindications to immediate internal fixation and understanding the myriad factors that negatively affect bone healing—from tobacco and NSAIDs to systemic comorbidities—is the hallmark of a master orthopaedic surgeon. By employing damage control strategies when necessary and optimizing the patient's biological envelope, the surgeon can navigate these treacherous clinical waters to achieve successful, functional outcomes.
